Johnson & Johnson announces that it will sponsor eight data presentations at the 2024 annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), to be held in Seattle from May 5 to 9, 2024.

In particular, J&J will highlight new research into the economic value of genetic testing for retinal diseases, and also show the role that automated algorithms based on deep learning can play for geographic atropia.

The laboratory will also present EYE-RD, a global registry that will collect real-world data, gathering more holistic information about disease progression and patient experiences.

' These data presented at ARVO 2024 demonstrate our commitment to bringing innovative new therapies that preserve and restore vision to patients worldwide, ' commented Hideo Makimura, Vice President and Global Head of Ophthalmology R&D at Johnson & Johnson Innovative Medicine.


Copyright (c) 2024 CercleFinance.com. All rights reserved.